Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Celltrion, Inc.
July 21, 2026
Celltrion, Inc.
Orphan Drug Designation
23 Academy-ro, Yeonsu-gu Incheon
1-50 employees
treatment of obstructive hypertrophic cardiomyopathy (oHCM)
Disease Area:
Rare Diseases
Source
July 21, 2026
Celltrion, Inc.
Orphan Drug Designation
23 Academy-ro, Yeonsu-gu Incheon
1-50 employees
Disease Area:
Rare Diseases
Source
Scroll to Top
